EAACI Congress 2024
BackFT 25 - Flash talks on Allergen Immunotherapy 4
Monday 03 Jun, 12:45 PM -
14:15 PM Valencia, Spain
Palma
Flash Talks
12:45
Understanding the Patient: Their Preferences for Venom Immunotherapy
12:52
Which patients should be checked with cross-reactive carbohydrate determinants-inhibition test before starting venom immunotherapy?
12:59
Effect of 300 IR house dust mite sublingual immunotherapy tablet in paediatric patients and relationship with disease activity
13:06
One-year follow-up of children who achieved sustained unresponsiveness following early oral immunotherapy for various allergens
13:13
Involving patients in the research process improves the clinical resolution of trial effect
13:20
Safety profile in clinical trials of sublingual immunotherapy with carbamylated monomeric allergoid
13:27
MRNA-delivered consensus nsLTP promotes a protective T cells profile in samples derived from patients allergic to multiple nsLTPs
13:34
Polistes gallicus: an alternative treatment for European paper wasp venom allergic patients?
13:41
Der p 23 quantification in a HDM allergoid and its clinical relevance
13:48
Comparison of the efficacy of subcutaneous and sublingual immunotherapy for the treatment of allergic asthma in children
13:55
Clinical Assessment of Specific Immunotherapy Efficacy in Individuals with House Dust Mite-Induced Allergic Rhinoconjunctivitis
14:02
Investigation of B-cells in allergy concordant and discordant twins
